Rezultati pretraživanja
  1. prije 2 sata
  2. prije 8 sati

    Still spellbound by 2020 Jephcott lecture by Sir . Fascinating talk on the unique technology, a Bicycle Drug Conjugate with a reduced molecular weight (for better tumour penetration) and profound specificity.

  3. prije 9 sati
  4. prije 12 sati

    helps reverse release syndrome induced by Blood purification tech used w/ continuous renal replacement therapy &

  5. At ClearLight Biotechnologies we enable modern heroes to see more biology and explore further with Tru3D™. Get Started with CLARITY and Tru3D.

  6. SITC board member, Dr. Daniel S. Chen, debates Dr. Carl H. June on bispecifics vs. cell therapy, and which will have a greater impact on cancer care at the 6th Annual IO360° () Summit, Feb 26-28 in NYC. Register today at:

  7. prije 16 sati
  8. prije 16 sati

    Very excited to announce our ! The support from our existing and new investors will enable us to advance our full-ecosystem biotherapeutics and expand their clinical application.

  9. prije 19 sati

    Read our Q&A on from Chris Learn & Martin Lachs regarding their success in the field. Read the full article here

  10. 4. velj

    Two exciting projects we are involved in, using non-adherent cells and HT flow cytometry with the iQue, are looking at re-activating “exhausted” T-cells so they can start kill cancer cells again. One is with in

  11. 4. velj

    Today we mark - in recognition of all those working to beat and transform lives

  12. 4. velj

    This World Cancer Day, we recognise that our commitment to act will lead to powerful progress in reducing the global impact of cancer. Together we can win the battle against

  13. Live on LinkedIn TOMORROW: Panelists Ralph Gareus (JAX) & Ana Zarubica (CIPHE, Marseille) talk about the many uses of humanized mice and how they are advancing research in Europe. Follow us on LinkedIn to get a notification when it starts:

  14. Looking forward to Ana Anderson's talk today on the effect of steroid hormone signaling on CD8 T cells in the TME. Today in TAC auditorium at 4pm.

  15. 4. velj

    - Congratulations to Emma Reungoat for her excellent presentation on 's preclinical mouse models!!! 👏👏👏

  16. 4. velj

    Hey, Biotech/Pharma, BD team will be in the Cambridge/Boston area February 4-7, 2020. Contact busdev@imaginab.com to schedule a meeting and learn more about using CD8 ImmunoPET in your .

  17. 4. velj

    20 years ago, was established to acknowledge the impact of cancer on human life and society. Aiming to fight , MorphoSys is developing therapies

  18. 1. velj

    Top Conferences for 2020. Click the link to download the spreadsheet. No signup necessary.

  19. 31. sij

    IO-focused biotechs can still employ traditional clinical trial parameters and processes, but considerations distinct to studies present unique scientific & operational challenges for even the most seasoned biotech executives.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.